The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Texas, issued a diagnosis for America's broken health care system, and he says the problem isn't what people think.

Novo Nordisk was slammed by a U.K. trade group for not disclosing payments to health and patient groups, according to a draft ...

Novo Nordisk (NVO) has reportedly been criticized by a U.K. pharma industry group for mischaracterizing certain payments to ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

Novo Nordisk (NVO) was slammed by a U.K. trade group for violating voluntary codes and discrediting the pharmaceutical industry over a failure ...

Novo Nordisk shares were 9.5% higher after the pharmaceutical giant said an experimental weight-loss shot showed patients ...

Medicare added Novo Nordisk's Ozempic ... the Medicare Part D prescription drug program paid a whopping $14.4 billion on the three drugs. The Inflation Reduction Act (IRA) of 2022 empowered ...

Analysts argue that as Novo and Lilly expand the use cases for GLP-1s, their competitive moats will grow even deeper. Meanwhile, Novo's aggressive DKK 19.4 billion share repurchase program signals ...

Few drugs have generated as much excitement as Novo Nordisk's (NYSE ... the Medicare Part D prescription drug program paid a whopping $14.4 billion on the three drugs. The Inflation Reduction ...

At the BCG event that sought to explore how digital health and AI are changing the healthcare industry, a Novo Nordisk executive —Thomas Senderovitz, senior vice president of data science ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...